Skip to main content
MNPR logo

MNPR · Monopar Therapeutics

$105.90 -5.22 (-4.70%) At close · Jul 20
Market Cap
$709.43M
Shares
6.70M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
99/100
Short interest 22.7% of shares — P99 Days to cover 8.6 — P94 Price vs VWAP +43.8% — P99 Short-volume trend +12.3% — P87 Short interest change -2.5% — P37 Worst FTD 0.57% of shares — P90 Volume surge +10

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 1,519,701 1,558,148 -38,447 8.61
2026-06-15 1,558,148 1,579,320 -21,172 12.54
2026-05-29 1,579,320 1,569,220 +10,100 8.53
2026-05-15 1,569,220 1,670,599 -101,379 8.05
2026-04-30 1,670,599 1,723,274 -52,675 10.60
2026-04-15 1,723,274 1,684,127 +39,147 9.34
2026-03-31 1,684,127 1,653,442 +30,685 7.98
2026-03-13 1,653,442 1,590,237 +63,205 10.45
2026-02-27 1,590,237 1,506,521 +83,716 10.83
2026-02-13 1,506,521 1,355,318 +151,203 5.11
2026-01-30 1,355,318 1,279,274 +76,044 4.26
2026-01-15 1,279,274 1,056,017 +223,257 4.07
2025-12-31 1,056,017 822,858 +233,159 3.11
2025-12-15 822,858 507,439 +315,419 4.55
2025-11-28 507,439 371,120 +136,319 4.04
2025-11-14 371,120 256,778 +114,342 1.99
2025-10-31 256,778 161,927 +94,851 2.58
2025-10-15 161,927 147,870 +14,057 1.71
2025-09-30 147,870 146,898 +972 1.76
2025-09-15 146,898 136,401 +10,497 3.92
2025-08-29 136,401 140,259 -3,858 3.25
2025-08-15 140,259 135,440 +4,819 5.44
2025-07-31 135,440 136,516 -1,076 6.70
Showing 1–23 of 23 settlements
Key facts CIK 1645469 CUSIP 61023L207 13F (30d) 4 filings 4 filers Visit website Investor relations